Synthesis, Spectral Analysis and Antimicrobial Activity of New Pd (II) Complexes Involving 5,6-Dimethylbenzimidazole
Murat Türkyilmaz , Murat Dönmez , Özlen Altun
Chemical Research in Chinese Universities ›› 2023, Vol. 39 ›› Issue (6) : 968 -975.
Synthesis, Spectral Analysis and Antimicrobial Activity of New Pd (II) Complexes Involving 5,6-Dimethylbenzimidazole
In this study, firstly, 3-bromopropanenitrile(2a), ethyl bromoacetate(2b), and 2-bromoethan-1-amine(2c) were added to 5,6-dimethylbenzimidazole(1) and symmetrically-connected N-heterocyclic carbenes(NHC)[(3a–3c)] were synthesized. Then, the NHC precursor compounds were reacted with PdCl2 and Pd (II)-NHC complexes[(4a—4c)] were obtained. The synthesized NHC precursors(3a–3c) and Pd( II)-NHC complexes(4a—4c) were characterized by different spectroscopic methods. The antibacterial activities of these products were measured against bacteria and fungus with the disc diffusion method. Pd(II)-NHC complexes had higher antibacterial activity than the NHC precursors. The synthesized compounds showed antimicrobial activity with different properties from each other. In vitro biological activities of salts and metal complexes on selected bacteria were determined by the broth dilution method based on Clinical and Laboratory Standards Institute guidelines. 1,3-Bis-(2-hydroxyethyl) imidazolinium bromide and 3-(2-ethoxy-2-oxoethyl)-1-(3-aminopropyl)-1H-imidazole-3-ium bromide had activity against Escherichia coli.
N-Heterocyclic carbene / Palladium(II)-NHC complex / Structural analysis / Antimicrobial activity
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
Clinical and Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Approved standard—Second Edition, 2002, Wayne, Pennsylvania: NCCLS Document M27-A2(ISBN 1-56238-469-4) |
| [32] |
Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, Twenty-second Informational Supplement, 2012, Wayne, Pennsylvania: CLSI Document M100-S22 |
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
/
| 〈 |
|
〉 |